Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today
announced results for the third quarter ended September 30,
2023.
Third Quarter Highlights
- Third quarter 2023 net revenue declined 40.2% to $39.7 million,
compared to $66.3 million in the third quarter of 2022.
- Third quarter 2023 gross margin increased to 49.4%, compared to
45.5% in the third quarter of 2022, primarily reflecting the impact
of improved pricing on inventory liquidations.
- Third quarter 2023 contribution margin increased to 3.0% from
1.1% in the third quarter of 2022, primarily reflecting the impact
of improved pricing on inventory liquidations.
- Third quarter 2023 operating loss of ($6.5) million decreased
compared to a loss of ($108.9) million in the third quarter of
2022, an improvement of 94.0%. Third quarter 2023 operating loss
includes ($1.2) million of non-cash stock compensation, and
restructuring costs of ($0.4) million, while third quarter 2022
operating loss included a gain of $0.8 million from the change in
fair value of earn-out liabilities, a non-cash loss of ($90.9)
million from the impairment on goodwill, a non-cash loss of ($3.1)
million on the impairment on intangibles and ($2.9) million of
non-cash stock compensation.
- Third quarter 2023 net loss of ($6.3) million decreased from a
($116.9) million loss in the third quarter of 2022, an improvement
of 94.6%. Third quarter 2023 net loss includes ($1.2) million of
non-cash stock compensation, restructuring costs of ($0.4) million,
and a gain on fair value of warrant liability of $0.6 million,
while third quarter 2022 net loss included a gain of $5.5 million
in net charges from the changes in fair value of warrants, a loss
of ($12.8) million from the derivative related to offering of
common stock, ($2.9) million of non-cash stock compensation, a gain
of $0.8 million from the change in fair value of earn-out
liabilities, a non-cash loss of ($90.9) million from the impairment
on goodwill, and a non-cash loss of ($3.1) million on the
impairment on intangibles.
- Third quarter 2023 adjusted EBITDA loss of ($4.4) million
decreased from a ($9.1) million loss in the third quarter of 2022,
an improvement of 51.3%.
- Total cash balance at September 30, 2023 was $28.0
million.
Fourth Quarter 2023 Outlook
For the fourth quarter 2023, taking into account
the current global environment and inflation, we believe that net
revenue will be between $28 million and $32 million and that
adjusted EBITDA loss will be between ($6.5) million to ($7.5)
million which includes an estimated incremental $2.0 million
negative impact from anticipated fourth quarter pricing initiatives
for higher price inventory in relation to Black Friday and Cyber
Monday Sale Programs.
The Company’s fourth quarter 2023 guidance is
based on a number of assumptions that are subject to change, any of
which are outside the Company’s control. If actual results vary
from these assumptions, the Company’s expectations may change.
There can be no assurance that the Company will achieve these
results.
Non-GAAP Financial Measures
For more information on our non-GAAP financial
measures and a reconciliation of GAAP to non-GAAP measures, please
see the “Non-GAAP Financial Measures” section below. The most
directly comparable GAAP financial measure for EBITDA and adjusted
EBITDA is net loss and we expect to report a net loss for the three
months ending December 31, 2023, due primarily to our operating
losses, which includes stock-based compensation expense, and
interest expense. We are unable to reconcile the forward-looking
statements of EBITDA and adjusted EBITDA in this press release to
their nearest GAAP measures because the nearest GAAP financial
measures are not accessible on a forward-looking basis and
reconciling information is not available without unreasonable
effort.
Webcast and Conference Call
Information
Aterian will host a live conference call to
discuss financial results today, November 8, 2023, at 5:00 p.m.
Eastern Time, which will be accessible by telephone and the
internet. To access the call, participants from within the U.S.
should dial (800) 715-9871 and participants from outside the U.S.
should dial (646) 307-1963 and ask to be joined into the Aterian,
Inc. call. Participants may also access the call through a live
webcast at https://ir.aterian.io. The archived online replay will
be available for a limited time after the call in the Investors
Relations section of the Aterian website.
About Aterian, Inc.
Aterian, Inc. (Nasdaq: ATER) is a
technology-enabled consumer product company that builds and
acquires leading e-commerce brands with top selling consumer
products, in multiple categories, including home and kitchen
appliances, health and wellness and air quality devices. By
leveraging its cloud-based platform, Artificial Intelligence
Marketplace Ecommerce Engine (AIMEE™), the Company sells across the
world's largest online marketplaces with a focus on Amazon and
Walmart and on its own direct to consumer websites.
Forward Looking Statements
All statements other than statements of
historical facts included in this press release that address
activities, events or developments that we expect, believe or
anticipate will or may occur in the future are forward-looking
statements including, in particular, the statements regarding our
projected fourth quarter net revenue and adjusted EBITDA, the
current global environment and inflation. These forward-looking
statements are based on management’s current expectations and
beliefs and are subject to a number of risks and uncertainties and
other factors, all of which are difficult to predict and many of
which are beyond our control and could cause actual results to
differ materially and adversely from those described in the
forward-looking statements. These risks include, but are not
limited to, those related to our ability to continue as a going
concern, our ability to meet financial covenants with our lenders,
our ability to maintain and to grow market share in existing and
new product categories; our ability to continue to profitably sell
the SKUs we operate; our ability to create operating leverage and
efficiency when integrating companies that we acquire, including
through the use of our team’s expertise, the economies of scale of
our supply chain and automation driven by our platform; those
related to our ability to grow internationally and through the
launch of products under our brands and the acquisition of
additional brands; those related to consumer demand, our cash
flows, financial condition, forecasting and revenue growth rate;
our supply chain including sourcing, manufacturing, warehousing and
fulfillment; our ability to manage expenses, working capital and
capital expenditures efficiently; our business model and our
technology platform; our ability to disrupt the consumer products
industry; our ability to generate profitability and stockholder
value; international tariffs and trade measures; inventory
management, product liability claims, recalls or other safety and
regulatory concerns; reliance on third party online marketplaces;
seasonal and quarterly variations in our revenue; acquisitions of
other companies and technologies and our ability to integrate such
companies and technologies with our business; our ability to
continue to access debt and equity capital (including on terms
advantageous to the Company) and the extent of our leverage; and
other factors discussed in the “Risk Factors” section of our most
recent periodic reports filed with the Securities and Exchange
Commission (“SEC”), all of which you may obtain for free on the
SEC’s website at www.sec.gov.
Although we believe that the expectations
reflected in our forward-looking statements are reasonable, we do
not know whether our expectations will prove correct. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof, even if
subsequently made available by us on our website or otherwise. We
do not undertake any obligation to update, amend or clarify these
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities laws.
ATERIAN, INC. Consolidated Balance
Sheets(in thousands, except share and per share
data) |
|
|
|
December 31,2022 |
|
September 30,2023 |
ASSETS |
|
|
|
|
Current
assets: |
|
|
|
|
Cash |
|
$ |
43,574 |
|
|
$ |
27,955 |
|
Accounts
receivable, net |
|
|
4,515 |
|
|
|
3,271 |
|
Inventory |
|
|
43,666 |
|
|
|
31,493 |
|
Prepaid
and other current assets |
|
|
8,261 |
|
|
|
5,963 |
|
Total
current assets |
|
|
100,016 |
|
|
|
68,682 |
|
Property
and equipment, net |
|
|
853 |
|
|
|
792 |
|
Other
intangibles, net |
|
|
54,757 |
|
|
|
12,016 |
|
Other
non-current assets |
|
|
813 |
|
|
|
541 |
|
Total
assets |
|
$ |
156,439 |
|
|
$ |
82,031 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
Current
Liabilities: |
|
|
|
|
Credit
facility |
|
$ |
21,053 |
|
|
$ |
14,182 |
|
Accounts
payable |
|
|
16,035 |
|
|
|
12,464 |
|
Seller
notes |
|
|
1,693 |
|
|
|
1,196 |
|
Accrued
and other current liabilities |
|
|
14,254 |
|
|
|
10,740 |
|
Total
current liabilities |
|
|
53,035 |
|
|
|
38,582 |
|
Other
liabilities |
|
|
1,452 |
|
|
|
1,540 |
|
Total
liabilities |
|
|
54,487 |
|
|
|
40,122 |
|
Commitments and contingencies |
|
|
|
|
Stockholders' equity: |
|
|
|
|
Common
stock, $0.0001 par value, 500,000,000 shares authorized and
80,752,290 and 89,132,183 shares outstanding at December 31, 2022
and September 30, 2023, respectively |
|
|
8 |
|
|
|
9 |
|
Additional paid-in capital |
|
|
728,339 |
|
|
|
735,110 |
|
Accumulated deficit |
|
|
(625,251 |
) |
|
|
(692,108 |
) |
Accumulated other comprehensive loss |
|
|
(1,144 |
) |
|
|
(1,102 |
) |
Total
stockholders’ equity |
|
|
101,952 |
|
|
|
41,909 |
|
Total
liabilities and stockholders' equity |
|
$ |
156,439 |
|
|
$ |
82,031 |
|
ATERIAN, INC.Consolidated Statements of
Operations(in thousands, except share and per share
data) |
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
Net
revenue |
|
$ |
66,326 |
|
|
$ |
39,668 |
|
|
$ |
166,268 |
|
|
$ |
109,811 |
|
Cost of
good sold |
|
|
36,135 |
|
|
|
20,085 |
|
|
|
81,118 |
|
|
|
56,236 |
|
Gross
profit |
|
|
30,191 |
|
|
|
19,583 |
|
|
|
85,150 |
|
|
|
53,575 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Sales
and distribution |
|
|
33,792 |
|
|
|
20,921 |
|
|
|
88,632 |
|
|
|
61,704 |
|
Research
and development |
|
|
1,706 |
|
|
|
852 |
|
|
|
4,582 |
|
|
|
3,808 |
|
General
and administrative |
|
|
10,369 |
|
|
|
4,326 |
|
|
|
29,481 |
|
|
|
16,566 |
|
Impairment loss on goodwill |
|
|
90,921 |
|
|
|
— |
|
|
|
119,941 |
|
|
|
— |
|
Impairment loss on intangibles |
|
|
3,118 |
|
|
|
— |
|
|
|
3,118 |
|
|
|
39,445 |
|
Change
in fair value of contingent earn-out liabilities |
|
|
(774 |
) |
|
|
— |
|
|
|
(5,240 |
) |
|
|
— |
|
Total
operating expenses |
|
|
139,132 |
|
|
|
26,099 |
|
|
|
240,514 |
|
|
|
121,523 |
|
Operating loss |
|
|
(108,941 |
) |
|
|
(6,516 |
) |
|
|
(155,364 |
) |
|
|
(67,948 |
) |
Interest
expense, net |
|
|
904 |
|
|
|
359 |
|
|
|
2,043 |
|
|
|
1,076 |
|
Gain on
extinguishment of seller note |
|
|
— |
|
|
|
— |
|
|
|
(2,012 |
) |
|
|
— |
|
Loss on
initial issuance of equity |
|
|
12,834 |
|
|
|
— |
|
|
|
18,669 |
|
|
|
— |
|
Change
in fair value of warrant liability |
|
|
(5,528 |
) |
|
|
(567 |
) |
|
|
2,365 |
|
|
|
(2,410 |
) |
Other
(income) expense, net |
|
|
(174 |
) |
|
|
(128 |
) |
|
|
(199 |
) |
|
|
101 |
|
Loss
before income taxes |
|
|
(116,977 |
) |
|
|
(6,180 |
) |
|
|
(176,230 |
) |
|
|
(66,715 |
) |
Provision (benefit) for income taxes |
|
|
(75 |
) |
|
|
90 |
|
|
|
(243 |
) |
|
|
142 |
|
Net
loss |
|
$ |
(116,902 |
) |
|
$ |
(6,270 |
) |
|
$ |
(175,987 |
) |
|
$ |
(66,857 |
) |
Net loss
per share, basic and diluted |
|
$ |
(1.81 |
) |
|
$ |
(0.08 |
) |
|
$ |
(2.78 |
) |
|
$ |
(0.86 |
) |
Weighted-average number of shares outstanding, basic and
diluted |
|
|
64,648,650 |
|
|
|
79,022,467 |
|
|
|
63,397,196 |
|
|
|
77,801,774 |
|
ATERIAN, INC.Consolidated Statements of Cash
Flows(in thousands) |
|
|
|
Nine Months Ended September 30, |
|
|
|
2022 |
|
|
|
2023 |
|
OPERATING ACTIVITIES: |
|
|
|
|
Net loss |
|
$ |
(175,987 |
) |
|
$ |
(66,857 |
) |
Adjustments to reconcile net
loss to net cash used by operating activities: |
|
|
|
|
Depreciation and
amortization |
|
|
5,763 |
|
|
|
3,416 |
|
Provision for sales
returns |
|
|
134 |
|
|
|
(215 |
) |
Amortization of deferred
financing cost and debt discounts |
|
|
321 |
|
|
|
321 |
|
Issuance of common stock |
|
|
43 |
|
|
|
— |
|
Stock-based compensation |
|
|
11,854 |
|
|
|
6,771 |
|
Gain from decrease of
contingent earn-out liability fair value |
|
|
(5,240 |
) |
|
|
— |
|
Change in inventory
provisions |
|
|
— |
|
|
|
213 |
|
Loss (gain) in connection with
the change in warrant fair value |
|
|
2,365 |
|
|
|
(2,410 |
) |
Gain in connection with
settlement of note payable |
|
|
(2,012 |
) |
|
|
— |
|
Loss on initial issuance of
equity |
|
|
18,669 |
|
|
|
— |
|
Impairment loss on
goodwill |
|
|
119,941 |
|
|
|
— |
|
Impairment loss on
intangibles |
|
|
3,118 |
|
|
|
39,445 |
|
Allowance for doubtful
accounts and other |
|
|
219 |
|
|
|
59 |
|
Changes in assets and
liabilities: |
|
|
|
|
Accounts receivable |
|
|
5,326 |
|
|
|
1,186 |
|
Inventory |
|
|
2,588 |
|
|
|
11,960 |
|
Prepaid and other current
assets |
|
|
3,351 |
|
|
|
1,942 |
|
Accounts payable, accrued and
other liabilities |
|
|
(9,994 |
) |
|
|
(4,289 |
) |
Cash used in operating
activities |
|
|
(19,541 |
) |
|
|
(8,458 |
) |
INVESTING ACTIVITIES: |
|
|
|
|
Purchase of fixed assets |
|
|
(29 |
) |
|
|
(80 |
) |
Purchase of Step and Go
assets |
|
|
— |
|
|
|
(125 |
) |
Cash used in investing
activities |
|
|
(29 |
) |
|
|
(205 |
) |
FINANCING ACTIVITIES: |
|
|
|
|
Proceeds from equity offering,
net of issuance costs |
|
|
27,007 |
|
|
|
— |
|
Repayments on note payable to
Smash |
|
|
(2,868 |
) |
|
|
(518 |
) |
Payment of Squatty Potty
earn-out |
|
|
(3,983 |
) |
|
|
— |
|
Borrowings from MidCap credit
facilities |
|
|
107,678 |
|
|
|
63,978 |
|
Repayments for MidCap credit
facilities |
|
|
(116,924 |
) |
|
|
(71,165 |
) |
Insurance obligation
payments |
|
|
(1,778 |
) |
|
|
(788 |
) |
Insurance financing
proceeds |
|
|
2,099 |
|
|
|
986 |
|
Cash provided (used) by
financing activities |
|
|
11,231 |
|
|
|
(7,507 |
) |
Foreign currency effect on
cash, cash equivalents, and restricted cash |
|
|
(936 |
) |
|
|
42 |
|
Net change in cash and
restricted cash for the year |
|
|
(9,275 |
) |
|
|
(16,128 |
) |
Cash and restricted cash at
beginning of year |
|
|
38,315 |
|
|
|
46,629 |
|
Cash and restricted cash at
end of year |
|
$ |
29,040 |
|
|
$ |
30,501 |
|
RECONCILIATION OF CASH AND
RESTRICTED CASH: |
|
|
|
|
Cash |
|
|
25,997 |
|
|
|
27,955 |
|
Restricted Cash—Prepaid and
other current assets |
|
|
2,914 |
|
|
|
2,417 |
|
Restricted cash—Other
non-current assets |
|
|
129 |
|
|
|
129 |
|
TOTAL CASH AND RESTRICTED
CASH |
|
$ |
29,040 |
|
|
$ |
30,501 |
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURES OF
CASH FLOW INFORMATION |
|
|
|
|
Cash paid for interest |
|
$ |
1,409 |
|
|
$ |
1,457 |
|
Cash paid for taxes |
|
$ |
58 |
|
|
$ |
90 |
|
NON-CASH INVESTING AND
FINANCING ACTIVITIES: |
|
|
|
|
Non-cash consideration paid to
contractors |
|
$ |
1,137 |
|
|
$ |
321 |
|
Fair value of warrants issued
in connection with equity offering |
|
$ |
18,982 |
|
|
$ |
— |
|
Issuance of common stock
related to exercise of warrants |
|
$ |
767 |
|
|
$ |
— |
|
Issuance of common stock |
|
$ |
43 |
|
|
$ |
— |
|
Exercise of prefunded
warrants |
|
$ |
15,309 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures
We believe that our financial statements and the
other financial data included in this Quarterly Report have been
prepared in a manner that complies, in all material respects, with
generally accepted accounting principles in the U.S. (“GAAP”).
However, for the reasons discussed below, we have presented certain
non-GAAP measures herein.
We have presented the following non-GAAP
measures to assist investors in understanding our core net
operating results on an on-going basis: (i) Contribution Margin;
(ii) Contribution margin as a percentage of net revenue; (iii)
EBITDA (iv) Adjusted EBITDA; and (v) Adjusted EBITDA as a
percentage of net revenue. These non-GAAP financial measures may
also assist investors in making comparisons of our core operating
results with those of other companies.
As used herein, Contribution margin represents
gross profit less e-commerce platform commissions, online
advertising, selling and logistics expenses (included in sales and
distribution expenses). As used herein, Contribution margin as a
percentage of net revenue represents Contribution margin divided by
net revenue. As used herein, EBITDA represents net loss plus
depreciation and amortization, interest expense, net and provision
for income taxes. As used herein, Adjusted EBITDA represents EBITDA
plus stock-based compensation expense, changes in fair-market value
of earn-outs, profit and loss impacts from the issuance of common
stock and/or warrants, changes in fair-market value of warrant
liability, litigation settlements, impairment on goodwill and
intangibles, gain from extinguishment of seller note, restructuring
expenses and other expenses, net. As used herein, Adjusted EBITDA
as a percentage of net revenue represents Adjusted EBITDA divided
by net revenue. Contribution margin, EBITDA and Adjusted EBITDA do
not represent and should not be considered as alternatives to loss
from operations or net loss, as determined under GAAP.
We present Contribution margin and Contribution
margin as a percentage of net revenue, as we believe each of these
measures provides an additional metric to evaluate our operations
and, when considered with both our GAAP results and the
reconciliation to gross profit, provides useful supplemental
information for investors. Specifically, Contribution margin and
Contribution margin as a Non-GAAP Financial Measure percentage of
net revenue are two of our key metrics in running our business. All
product decisions made by us, from the approval of launching a new
product and to the liquidation of a product at the end of its life
cycle, are measured primarily from Contribution margin and/or
Contribution margin as a percentage of net revenue. Further, we
believe these measures provide improved transparency to our
stockholders to determine the performance of our products prior to
fixed costs as opposed to referencing gross profit alone.
In the reconciliation to calculate contribution
margin, we add e-commerce platform commissions, online advertising,
selling and logistics expenses (“sales and distribution variable
expense”) to gross profit to inform users of our financial
statements of what our product profitability is at each period
prior to fixed costs (such as sales and distribution expenses such
as salaries as well as research and development expenses and
general administrative expenses). By excluding these fixed costs,
we believe this allows users of our financial statements to
understand our products performance and allows them to measure our
products performance over time.
We present EBITDA, Adjusted EBITDA and Adjusted
EBITDA as a percentage of net revenue because we believe each of
these measures provides an additional metric to evaluate our
operations and, when considered with both our GAAP results and the
reconciliation to net loss, provide useful supplemental information
for investors. We use these measures with financial measures
prepared in accordance with GAAP, such as sales and gross margins,
to assess our historical and prospective operating performance, to
provide meaningful comparisons of operating performance across
periods, to enhance our understanding of our operating performance
and to compare our performance to that of our peers and
competitors. We believe EBITDA, Adjusted EBITDA and Adjusted EBITDA
as a percentage of net revenue are useful to investors in assessing
the operating performance of our business without the effect of
non-cash items.
Contribution margin, Contribution margin as a
percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted
EBITDA as a percentage of net revenue should not be considered in
isolation or as alternatives to net loss, loss from operations or
any other measure of financial performance calculated and
prescribed in accordance with GAAP. Neither EBITDA, Adjusted EBITDA
or Adjusted EBITDA as a percentage of net revenue should be
considered a measure of discretionary cash available to us to
invest in the growth of our business. Our Contribution margin,
Contribution margin as a percentage of net revenue, EBITDA,
Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue
may not be comparable to similar titled measures in other
organizations because other organizations may not calculate
Contribution margin, Contribution margin as a percentage of net
revenue, EBITDA, Adjusted EBITDA or Adjusted EBITDA as a percentage
of net revenue in the same manner as we do. Our presentation of
Contribution margin and Adjusted EBITDA should not be construed as
an inference that our future results will be unaffected by the
expenses that are excluded from such terms or by unusual or
non-recurring items.
We recognize that EBITDA, Adjusted EBITDA and
Adjusted EBITDA as a percentage of net revenue, have limitations as
analytical financial measures. For example, neither EBITDA nor
Adjusted EBITDA reflects:
- our capital expenditures or future requirements for capital
expenditures or mergers and acquisitions;
- the interest expense or the cash requirements necessary to
service interest expense or principal payments, associated with
indebtedness;
- depreciation and amortization, which are non-cash charges,
although the assets being depreciated and amortized will likely
have to be replaced in the future, or any cash requirements for the
replacement of assets;
- changes in cash requirements for our working capital needs;
or
- changes in fair value of contingent earn-out liabilities,
warrant liabilities, and amortization of inventory step-up from
acquisitions (included in cost of goods sold).
Additionally, Adjusted EBITDA excludes non-cash
stock-based compensation expense, which is and is expected to
remain a key element of our overall long-term incentive
compensation package.
We also recognize that Contribution margin and
Contribution margin as a percentage of net revenue have limitations
as analytical financial measures. For example, Contribution margin
does not reflect:
- general and administrative expense necessary to operate our
business; •research and development expenses necessary for the
development, operation and support of our software platform;
- the fixed costs portion of our sales and distribution expenses
including stock-based compensation expense; or
- changes in fair value of contingent earn-out liabilities,
warrant liabilities, and amortization of inventory step-up from
acquisitions (included in cost of goods sold).
Contribution Margin
The following table provides a reconciliation of
Contribution margin to gross profit and Contribution margin as a
percentage of net revenue to gross profit as a percentage of net
revenue, which are the most directly comparable financial measures
presented in accordance with GAAP:
|
Three Months Ended September
30, |
|
Nine Months Ended September
30, |
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
(in thousands, except percentages) |
Gross
Profit |
$ |
30,191 |
|
|
$ |
19,583 |
|
|
$ |
85,150 |
|
|
$ |
53,575 |
|
Less: |
|
|
|
|
|
|
|
E-commerce platform commissions, online advertising, selling and
logistics expenses |
|
(29,448 |
) |
|
|
(18,379 |
) |
|
|
(74,927 |
) |
|
|
(51,572 |
) |
Contribution margin |
$ |
743 |
|
|
$ |
1,204 |
|
|
$ |
10,223 |
|
|
$ |
2,003 |
|
Gross
Profit as a percentage of net revenue |
|
45.5 |
% |
|
|
49.4 |
% |
|
|
51.2 |
% |
|
|
48.8 |
% |
Contribution margin as a percentage of net revenue |
|
1.1 |
% |
|
|
3.0 |
% |
|
|
6.1 |
% |
|
|
1.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
The following table provides a reconciliation of
EBITDA and Adjusted EBITDA to net loss, which is the most directly
comparable financial measure presented in accordance with GAAP:
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
(in thousands, except percentages) |
Net loss |
$ |
(116,902 |
) |
|
$ |
(6,270 |
) |
|
$ |
(175,987 |
) |
|
$ |
(66,857 |
) |
Add: |
|
|
|
|
|
|
|
Provision (benefit) for income
taxes |
|
(75 |
) |
|
|
90 |
|
|
|
(243 |
) |
|
|
142 |
|
Interest expense, net |
|
904 |
|
|
|
359 |
|
|
|
2,043 |
|
|
|
1,076 |
|
Depreciation and
amortization |
|
1,869 |
|
|
|
452 |
|
|
|
5,763 |
|
|
|
3,416 |
|
EBITDA |
|
(114,204 |
) |
|
|
(5,369 |
) |
|
|
(168,424 |
) |
|
|
(62,223 |
) |
Other (income) expense,
net |
|
(174 |
) |
|
|
(128 |
) |
|
|
(199 |
) |
|
|
101 |
|
Change in fair value of
contingent earn-out liabilities |
|
(774 |
) |
|
|
— |
|
|
|
(5,240 |
) |
|
|
— |
|
Impairment loss on
goodwill |
|
90,921 |
|
|
|
— |
|
|
|
119,941 |
|
|
|
— |
|
Impairment loss on
intangibles |
|
3,118 |
|
|
|
— |
|
|
|
3,118 |
|
|
|
39,445 |
|
Gain on extinguishment of
seller note |
|
— |
|
|
|
— |
|
|
|
(2,012 |
) |
|
|
— |
|
Change in fair market value of
warrant liability |
|
(5,528 |
) |
|
|
(567 |
) |
|
|
2,365 |
|
|
|
(2,410 |
) |
Loss on original issuance of
equity |
|
12,834 |
|
|
|
— |
|
|
|
18,669 |
|
|
|
— |
|
Litigation reserve |
|
1,800 |
|
|
|
— |
|
|
|
2,600 |
|
|
|
— |
|
Restructuring expense |
|
— |
|
|
|
417 |
|
|
|
— |
|
|
|
1,633 |
|
Stock-based compensation
expense |
|
2,943 |
|
|
|
1,232 |
|
|
|
11,854 |
|
|
|
6,771 |
|
Adjusted EBITDA |
$ |
(9,064 |
) |
|
$ |
(4,415 |
) |
|
$ |
(17,328 |
) |
|
$ |
(16,683 |
) |
Net loss as a percentage of
net revenue |
|
(176.3 |
)% |
|
|
(15.8 |
)% |
|
|
(105.8 |
)% |
|
|
(60.9 |
)% |
Adjusted EBITDA as a
percentage of net revenue |
|
(13.7 |
)% |
|
|
(11.1 |
)% |
|
|
(10.4 |
)% |
|
|
(15.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Each of our products typically goes through the
Launch phase and depending on its level of success is moved to one
of the other phases as further described below:
i.
Launch phase: During this phase, we leverage our technology to
target opportunities identified using AIMEE (Artificial
Intelligence Marketplace e-Commerce Engine) and other sources. This
phase also includes revenue from new product variations and
relaunches. During this period of time, due to the combination of
discounts and investment in marketing, our net margin for a product
could be as low as approximately negative 35%. Net margin is
calculated by taking net revenue less the cost of goods sold, less
fulfillment, online advertising and selling expenses. These
primarily reflect the estimated variable costs related to the sale
of a product.
ii
Sustain phase: Our goal is for every product we launch to enter the
sustain phase and become profitable, with a target of positive 15%
net margin for most products, within approximately three months of
launch on average. Net margin primarily reflects a combination of
manual and automated adjustments in price and marketing spend.
iii.
Liquidate phase: If a product does not enter the sustain phase or
if the customer satisfaction of the product (i.e., ratings) is not
satisfactory, then it will go to the liquidate phase and we will
sell through the remaining inventory. Products can also be
liquidated as part of inventory normalization especially when steep
discounts are required.
The following tables break out our second
quarter of 2022 and 2023 results of operations by our product
phases (in thousands):
|
|
|
|
Three months ended September 30, 2022 |
|
|
|
|
|
|
Sustain |
|
Launch |
|
Liquidation/ Other |
|
Fixed Costs |
|
Stock Based Compensation |
|
Total |
Net revenue |
|
$ |
54,164 |
|
|
$ |
1,625 |
|
|
$ |
10,537 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
66,326 |
|
Cost of
goods sold |
|
|
25,351 |
|
|
|
943 |
|
|
|
9,841 |
|
|
|
— |
|
|
|
— |
|
|
|
36,135 |
|
Gross
profit |
|
|
28,813 |
|
|
|
682 |
|
|
|
696 |
|
|
|
— |
|
|
|
— |
|
|
|
30,191 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and distribution expenses |
|
|
23,182 |
|
|
|
803 |
|
|
|
5,463 |
|
|
|
3,345 |
|
|
|
999 |
|
|
|
33,792 |
|
Research
and development |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,195 |
|
|
|
511 |
|
|
|
1,706 |
|
General
and administrative |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,936 |
|
|
|
1,433 |
|
|
|
10,369 |
|
Impairment loss on goodwill |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
90,921 |
|
|
|
— |
|
|
|
90,921 |
|
Impairment loss on intangibles |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,118 |
|
|
|
— |
|
|
|
3,118 |
|
Change
in earn-out liability |
|
|
|
|
|
|
|
|
(774 |
) |
|
|
|
|
(774 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, 2023 |
|
|
|
|
|
|
Sustain |
|
Launch |
|
Liquidation/ Other |
|
Fixed Costs |
|
Stock Based Compensation |
|
Total |
Net revenue |
|
$ |
32,315 |
|
|
$ |
395 |
|
|
$ |
6,958 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
39,668 |
|
Cost of goods sold |
|
|
14,999 |
|
|
|
207 |
|
|
|
4,879 |
|
|
|
— |
|
|
|
— |
|
|
|
20,085 |
|
Gross
profit |
|
|
17,316 |
|
|
|
188 |
|
|
|
2,079 |
|
|
|
— |
|
|
|
— |
|
|
|
19,583 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution
expenses |
|
|
14,279 |
|
|
|
224 |
|
|
|
3,876 |
|
|
|
2,212 |
|
|
|
330 |
|
|
|
20,921 |
|
Research and development |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
574 |
|
|
|
278 |
|
|
|
852 |
|
General and
administrative |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,702 |
|
|
|
624 |
|
|
|
4,326 |
|
|
|
|
|
Nine months ended September 30, 2022 |
|
|
|
|
|
|
Sustain |
|
Launch |
|
Liquidation/ Other |
|
Fixed Costs |
|
Stock Based Compensation |
|
Total |
Net revenue |
|
$ |
146,207 |
|
|
$ |
3,804 |
|
|
$ |
16,257 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
166,268 |
|
Cost of
goods sold |
|
|
65,358 |
|
|
|
2,097 |
|
|
|
13,663 |
|
|
|
— |
|
|
|
— |
|
|
|
81,118 |
|
Gross
profit |
|
|
80,849 |
|
|
|
1,707 |
|
|
|
2,594 |
|
|
|
— |
|
|
|
— |
|
|
|
85,150 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and distribution expenses |
|
|
63,295 |
|
|
|
1,971 |
|
|
|
9,661 |
|
|
|
9,477 |
|
|
|
4,228 |
|
|
|
88,632 |
|
Research
and development |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,164 |
|
|
|
1,418 |
|
|
|
4,582 |
|
General
and administrative |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
23,273 |
|
|
|
6,208 |
|
|
|
29,481 |
|
Impairment loss on goodwill |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
119,941 |
|
|
|
— |
|
|
|
119,941 |
|
Impairment loss on intangibles |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,118 |
|
|
|
— |
|
|
|
3,118 |
|
Change
in earn-out liability |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5,240 |
) |
|
|
— |
|
|
|
(5,240 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2023 |
|
|
|
|
|
|
Sustain |
|
Launch |
|
Liquidation/ Other |
|
Fixed Costs |
|
Stock Based Compensation |
|
Total |
Net revenue |
|
$ |
91,931 |
|
|
$ |
595 |
|
|
$ |
17,285 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
109,811 |
|
Cost of goods sold |
|
|
43,182 |
|
|
|
319 |
|
|
|
12,735 |
|
|
|
— |
|
|
|
— |
|
|
|
56,236 |
|
Gross
profit |
|
|
48,749 |
|
|
|
276 |
|
|
|
4,550 |
|
|
|
— |
|
|
|
— |
|
|
|
53,575 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution
expenses |
|
|
41,473 |
|
|
|
376 |
|
|
|
9,723 |
|
|
|
8,041 |
|
|
|
2,091 |
|
|
|
61,704 |
|
Research and development |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,674 |
|
|
|
1,134 |
|
|
|
3,808 |
|
General and
administrative |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,020 |
|
|
|
3,546 |
|
|
|
16,566 |
|
Impairment loss on
intangibles |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
39,445 |
|
|
|
— |
|
|
|
39,445 |
|
Investor Contact:
Ilya Grozovsky
Vice President, Investor Relations & Corporate Development
Aterian, Inc.
ilya@aterian.io
917-905-1699
aterian.io
Grafico Azioni Aterian (NASDAQ:ATER)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Aterian (NASDAQ:ATER)
Storico
Da Gen 2024 a Gen 2025